Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Restructuring Costs (2020 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 6 years of Restructuring Costs data on record, last reported at -$115000.0 in Q1 2025.

  • For Q1 2025, Restructuring Costs fell 100.37% year-over-year to -$115000.0; the TTM value through Feb 2025 reached $62.5 million, up 2.53%, while the annual FY2025 figure was -$1.7 million, 205.5% down from the prior year.
  • Restructuring Costs reached -$115000.0 in Q1 2025 per LFCR's latest filing, down from $31.6 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $31.6 million in Q2 2024 and bottomed at -$115000.0 in Q1 2025.
  • Average Restructuring Costs over 5 years is $9.8 million, with a median of $1.4 million recorded in 2021.
  • Peak YoY movement for Restructuring Costs: skyrocketed 395050.0% in 2024, then tumbled 100.37% in 2025.
  • A 5-year view of Restructuring Costs shows it stood at $1.8 million in 2021, then plummeted by 69.3% to $563000.0 in 2022, then crashed by 72.11% to $157000.0 in 2023, then surged by 20035.03% to $31.6 million in 2024, then plummeted by 100.36% to -$115000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Restructuring Costs were -$115000.0 in Q1 2025, $31.6 million in Q2 2024, and $30.9 million in Q1 2024.